CTD 12.5 mg Ipca Laboratories Ltd

21.00

SKU: EU14232 Categories: ,

Description

Overview of CTD 12.5 mg Ipca Laboratories Ltd

CTD 12.5 mg, produced by Ipca Laboratories Ltd, is a pharmaceutical product designed primarily for athletes looking to enhance their performance and recovery. Established in 1949, Ipca Laboratories has established itself as a significant player in the pharmaceutical industry, focusing on high-quality medications and innovative solutions. CTD, or clomiphene citrate, is the active ingredient in this formulation, which is traditionally used to treat fertility issues but has found a loyal following in sports pharmacology due to its anabolic properties. The tablet contains 12.5 mg of clomiphene citrate, complemented by various excipients that ensure stability and bioavailability.

Physiological impact, what happens in the body

When introduced into the body, CTD 12.5 mg triggers various physiological responses that can significantly impact athletic performance and recovery. Clomiphene citrate primarily acts as a selective estrogen receptor modulator (SERM). It raises the levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), both critical hormones involved in testosterone production. Increased testosterone levels can lead to enhanced muscle growth, improved strength, and better overall athletic performance. Additionally, CTD has the potential to improve recovery times by reducing muscle fatigue, promoting faster healing of micro-tears after intense workouts. This makes it a sought-after substance in the sports community where physical demands are high.

How to acquire CTD 12.5 mg Ipca Laboratories Ltd, purchasing instructions

Acquiring CTD 12.5 mg from Ipca Laboratories can be done through various channels, but it is imperative to do so legally and safely. Athletes should start by consulting with a healthcare professional who is familiar with sports pharmacology to discuss suitability and appropriate dosage. Following a consultation, interested individuals can look for authorized pharmacies, either brick-and-mortar or online, that specialize in sports medication. It is crucial to ensure that the pharmacy is legitimate and licensed in their jurisdiction. Athletes should avoid purchasing CTD from unverified or dubious sources, as this can lead to counterfeit products that may have harmful side effects.

Contraindications, who should avoid it

While CTD 12.5 mg has gained popularity among athletes, it is not suitable for everyone. Certain contraindications should be considered before use. Individuals with a history of liver disease, hormonal disorders, or certain types of cancer, particularly those sensitive to estrogen, should avoid using CTD. Furthermore, women who are pregnant or breastfeeding should not take this medication, as it may pose risks to both the mother and child. It is also advisable for individuals with a history of blood clots or other serious health conditions to consult a healthcare provider before use.

Key effects, main reasons for use

CTD 12.5 mg is associated with several key effects that appeal to athletes and fitness enthusiasts. The primary reasons for its use include:

  1. Enhanced testosterone production
  2. Improved muscle growth
  3. Increased strength and endurance
  4. Faster recovery from workouts
  5. Reduction in muscle fatigue

These effects contribute to better athletic performance, making CTD a sought-after option in the realm of sports pharmacology. Nonetheless, users should always conduct thorough research and evaluate potential risks before starting any new regimen.

Additional information

Active substance

Chlorthalidone

Water Retention

Reduces water retention

Hepatotoxicity

Minimal risk

Lab Test

Can affect electrolyte and glucose levels

Strength

12.5mg

Also known as

Chlortalidone

Blood pressure

Lowers blood pressure

Trade name

Hygroton, Thalitone

Storage conditions

Store at room temperature away from moisture and heat

Chemical name

2-Chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide

Formula

C14H11ClN2O4S

Substance class

Thiazide-like diuretic

Main action

Diuresis and antihypertensive

Half-life

Approximately 40 to 60 hours

Dosage (medical)

Commonly 12.5 mg to 25 mg daily for hypertension

Dosage (sports)

Not applicable for sports enhancement

Effects

Reduces blood pressure, decreases fluid retention

Side effects

Dizziness, dehydration, hypokalemia, hyperglycemia, increased uric acid

Use in sports

Not typically used in sports, potential for misuse in weight class sports for rapid weight loss

Manufacturer

Ipca Laboratories Ltd

Packing

15 tabs/blister

Reviews

There are no reviews yet.

Be the first to review “CTD 12.5 mg Ipca Laboratories Ltd”

CTD 12.5 mg Ipca Laboratories Ltd
21.00